EquipNet, a leading provider of surplus asset management solutions based in Canton, Mass., has announced in a press release that it has entered a reseller agreement with California-based Agilent ...
In a world first, researchers at the Kennedy Institute, Oxford have mapped the cellular dynamics following treatment with the ...
We recently published a list of 10 Best Depressed Stocks To Buy Heading into 2025. In this article, we are going to take a ...
GlobalData on MSN15h
A slow start for self-amplifying mRNA vaccinesA year after the first samRNA vaccine approval, experts say similar vaccines in development are likely to face scientific and ...
In one of our recent articles about 10 High Growth Non-Tech Stocks That Are Profitable in 2024, we talked about how the US ...
Hosted on MSN1d
Earnings Preview: What to Expect From Moderna's ReportBased in Cambridge, Massachusetts, Moderna, Inc. (MRNA) is a leading biotechnology company that develops messenger RNA (mRNA) ...
European Patent Office to grant a patent for DRP® companion diagnostic for Allarity’s stenoparib cancer therapyPatent applications for the ...
Early data from Wave Life Sciences suggests how editing RNA may yield viable medicines. Large and small drugmakers say such ...
Altered RNA processing is highly damaging to neurons, adding a new toxic component to the evolution of AD. Currently, the ...
Two public companies focused on RNA editing therapies, Korro Bio and ProQR, enjoyed impressive stock surges powered by their best-ever one day gains; their share prices lifted by Wave Life Sciences ...
Review explores how microRNAs (miRNAs) interact in cancer development, their potential in diagnosis, and innovative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback